(Reuters) - Unilever Plc said on Monday it had agreed to buy GlaxoSmithKline's health food and drinks portfolio in India, Bangladesh and 20 other predominantly Asian markets.

Unilever's share of the total deal price is 3.3 billion euros ($3.75 billion), payable using cash, and shares in its subsidiary in India, Hindustan Unilever Limited.

The portfolio includes brands such as Horlicks and Boost.

($1 = 0.8805 euros)

(Reporting by Noor Zainab Hussain in Bengaluru; Editing by Sai Sachin Ravikumar)

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)